Quantification of Sphingosine-1-Phosphate (S1P) in Patients with Periodontitis Stage II Grade B
DOI:
https://doi.org/10.15517/ijds.2022.48877Keywords:
Periodontitis; Sphingosine-1-Phosphate; Osteoclastogenesis; Inflammation; Saliva; Gingival crevicular fluid.Abstract
The aim of this study was the quantification of Sphingosine-1-phosphate (S1P) in periodontal pockets of patients with periodontitis. This is an observational, descriptive, case-control study. Thirty subjects were selected: 15 controls and 15 cases. A periodontal study was conducted following the parameters of AAP 2017 for the diagnosis of periodontal diseases. A sample of saliva and gingival crevicular fluid was obtained from each subject and then analyzed with the Human S1P Elisa kit (MyBioSource #MBS2516132) accordingly to the manufacturer's instructions, in order to verify the presence of S1P and quantify it´s concentration when founded. Results showed a significant difference (p=0.05) between cases and controls. In the case of saliva samples, the concentration of S1P was higher than the ones found in the control group (72.94 ng/mL and 45.12 ng/mL). For GCF, a higher amount of S1P was found in patients with POD (20.09 ng/mL and 15.20 ng/mL). This work raises a possible route of bone metabolism, inflammatory process, and identification of periodontitis through oral quantification of S1P, however, future studies are needed.
Downloads
References
Barbato L., Francioni E., Bianchi M., Mascitelli E., Brancato L., Tonelli D. Periodontitis and bone metabolism. Clin Cases in Miner Bone Metab. 2015; 12 (2): 174-177. DOI: https://doi.org/10.11138/ccmbm/2015.12.2.174
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015; 15 (1): 30-44. DOI: https://doi.org/10.1038/nri3785
Baeza M., Garrido M., Hernandez-Rios P., Dezerega A., Garcıa-Sesnich J., Strauss F., Aitken J.P., Lesaffre E., Vanbelle S., Gamonal J., Brignardello-Petersen R., Tervahartiala T., Sorsa T, Hernandez M. Diagnostic accuracy for apical and chronic periodontitis biomarkers in gingival crevicular fluid: an exploratory study. J Clin Periodontol. 2016; 43 (1): 34-45 DOI: https://doi.org/10.1111/jcpe.12479
Bostanci N., Belibasakis G. Gingival crevicular fluid and its immune mediators in the proteomic era. Periodontol 2000. 2018; 76 (1): 68-84. DOI: https://doi.org/10.1111/prd.12154
Suchetha A., Shahna N., Sapna N., Darshan B., Apoorva S., Bhat D. Gingival crevicular fluid: A Review of literature. Annals of Dental Specialty. 2018; 6 (2): 211-216.
Duvina M., Barbato L., Brancato L., Delle Rose G., Amunni F., Tonelli P. Biochemical markers as predictors of bone remodelling in dental disorders: a narrative description of literature. Clin cases in Miner Bone Metab. 2012; 9 (2): 100-106.
Taubman M., Valverde P., Han X., Kawai T. Immune Response: The Key to Bone Resorption in Periodontal Disease. J Periodontol. 2005; 76 (11): 2033-2041. DOI: https://doi.org/10.1902/jop.2005.76.11-S.2033
Naruishi K., Nagata T. Biological effects of interleukin 6 on Gingival Fibroblasts: Cytokine regulation in periodontitis. J Cell Physiol. 2018; 233 (9): 6393-400. DOI: https://doi.org/10.1002/jcp.26521
Wright H., McCarthy H.S., Middleton J., Marshall M. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med. 2009; 2 (1): 56-64. DOI: https://doi.org/10.1007/s12178-009-9046-7
Nagasawa T., Kiji M., Yashiro R., Hormdee D., Lu H., Kunze M., Suda T., Koshy G., Kobayashi H., Oda S., Nitta H., Ishikawa, I. Roles of receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000. 2007; 43 (1): 65-84. DOI: https://doi.org/10.1111/j.1600-0757.2006.00185.x
Kapasa E., Giannoudis P., Jia X., Yang X. The effect of rankl/opg balance on reducing implant complications. J Funct Biomater. 2017; 8 (4): 42:2-10. DOI: https://doi.org/10.3390/jfb8040042
Reynolds G.M., Visentin B., Sabbadini R. Immunohistochemical Detection of Sphingosine-1-Phosphate and Sphingosine Kinase-1 in Human Tissue Samples and Cell Lines. Methods Mol Biol. 2018; 1697: 43-56. DOI: https://doi.org/10.1007/7651_2017_44
Meshcheryakova A., Mechtcheriakova D., Pietschmann P. Sphingosine 1-phosphate signaling in bone remodeling: Multifaceted roles and therapeutic potential. Expert Opin Ther Targets.2017; 21 (7): 725-737. DOI: https://doi.org/10.1080/14728222.2017.1332180
Xiao L., Zhou Y., Friis T., Beagley K. and Xiao Y. S1P-S1PR1 Signaling: the “Sphinx” in Osteoimmunology. Front. Immunol. 2019; 10: 1409:1-18. DOI: https://doi.org/10.3389/fimmu.2019.01409
Ishii M., & Kikuta J. Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. Biochim Biophys Acta. 2013; 1831 (1): 223-227. DOI: https://doi.org/10.1016/j.bbalip.2012.06.002
Yu H., Sun C., Argraves K. Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1- deficient mice. J Periodont Res. 2016; 51 (1): 38-49. DOI: https://doi.org/10.1111/jre.12276
Ishii M., Egen J.G., Klauschen F., Meier-Schellersheim M., Saeki, Y., Vacher J., Germain R.N. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009; 458 (7237): 524-528. DOI: https://doi.org/10.1038/nature07713
Ishii M., Shimazu Y., Meier-Schellersheim M., Germain R. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling invivo. J Exp Med. 2010; 207 (13): 2793-2798. DOI: https://doi.org/10.1084/jem.20101474
Aoki M., Aoki H., Ramanathan R., C. Hait N., Takabe K. Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential. Mediators of Inflamm. 2016; 2016: 1-11. DOI: https://doi.org/10.1155/2016/8606878
Maceyka M., Harikumar K., Milstien S., Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012; 22 (1): 50-60. DOI: https://doi.org/10.1016/j.tcb.2011.09.003
Caton, J., Armitage, G., Berglundh, T., et al. A new classification scheme for periodontal and peri-implant diseases and conditions- Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018; 45 (20): S1-S8. DOI: https://doi.org/10.1111/jcpe.12935
Dame Z., Aziat F., Mandal R., Krishnamurthy R,1Bouatra S, Borzoui S, et al. The Human Saliva Metabolome. Metabolomics. 2015; 11 (1): 864-83. DOI: https://doi.org/10.1007/s11306-015-0840-5
Leppilahti, J.M., Hernández-Ríos, P.A., Gamonal, J.A., Tervahartiala, T., Brignardello-Petersen, R, Mantyla, P, Sorsa, T, Hernández, M. Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. J Clin Periodontol. 2014; 41: 348-356. DOI: https://doi.org/10.1111/jcpe.12223
Gamonal J., Bascones A., Jorge O., Silva A. Chemokine RANTES in gingival crevicular fluid of Adult patients with periodontitis. J Clin Periodontol. 2000; 27: 675-681. DOI: https://doi.org/10.1034/j.1600-051x.2000.027009675.x
Navazesh, M. Methods for collecting saliva. Ann Ny Acad Sci. 1993; 694 (1): 72-77. DOI: https://doi.org/10.1111/j.1749-6632.1993.tb18343.x
Spring Bio Science. Phosphate Buffered Saline with Tween 20 (20x). California. 2012.
World Health Organization. Obesity and overweight. OMS April 2020. URL: https://www.who.int/es/news-room/fact-sheets/detail/obesity-and-overweight. Accessed May 2020.
Sartawi Z., Schipani E., Ryan K., Waeber C. Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair. Pharmacol Res. 2017; 125: 232-245. DOI: https://doi.org/10.1016/j.phrs.2017.08.013
Hutami I., Tanaka E., Izawa T. Crosstalk between Fas and S1P1 signaling via NF-kB in osteoclasts controls bone destruction in the TMJ due to rheumatoid arthritis. Jpn Dent Sci Rev. 2019: 55 (1):12-19. DOI: https://doi.org/10.1016/j.jdsr.2018.09.004
Obinata H., Hla T. Sphingosine 1-phosphate and inflammation. Int immunol. 2019; 31 (9): 617-625. DOI: https://doi.org/10.1093/intimm/dxz037
Proia R., Hla T. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest. 2015; 125 (4): 1379-1387. DOI: https://doi.org/10.1172/JCI76369
Xiao Y., Wu J., Yuan Y., Guo X., Chen B., Huang Q. Effect of moesin phosphorylation on high-dose sphingosine-1-phosphate-induced endothelial responses. Mol Med Rep. 2018; 17 (1): 1933-1939. DOI: https://doi.org/10.3892/mmr.2017.8029
Keller J., Catala-Lehnen P., Huebner A., Jeschke A., Heckt T., Lueth A., Schilling S., et. al. Calcitonin controls bone formation by inhibiting the release of sphingosine 1- phosphate from osteoclasts. Nat Commun. 2014; 5: 5215:1-13. DOI: https://doi.org/10.1038/ncomms6215
Khavandgar Z., Murshed M. Sphingolipid metabolism and its role in the skeletal tissues. Cell Mol Life Sci. 2015; 72 (5): 959-969. DOI: https://doi.org/10.1007/s00018-014-1778-x
Barembaum S., Azcurra A. La saliva: una potencial herramienta en la Odontología. Rev Fac Odont. 2019; 29 (2): 9-21. DOI: https://doi.org/10.25014/revfacodont271.2019.2.9
Koss M., Castro C., Salúm K., López M. Changes in saliva protein composition in patients with periodontal disease. Acta Odontológica Latinoamericana. 2009; 22 (2): 105-112.
Gohda M., Kunisawa J., Miura F., Kagiyama Y., Kurashima Y., Higuchi, M., et al. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer’s patches for intestinal IgA responses. J Immunol. 2008; 180 (8): 5335- 5343. DOI: https://doi.org/10.4049/jimmunol.180.8.5335
Published
Issue
Section
License
Copyright (c) 2021 CC-BY-NC-SA 4.0
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
ODOVTOS - Int. J. Dent. Sc. endorses CC BY-NC-SA
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms. CC BY-NC-SA includes the following elements:
BY: credit must be given to the creator.
NC: Only noncommercial uses of the work are permitted.
SA: Adaptations must be shared under the same terms.
